PF-3644022   Click here for help

GtoPdb Ligand ID: 8045

Synonyms: PF 3644022 | PF3644022
PDB Ligand
Compound class: Synthetic organic
Comment: PF-3644022 is an experimental inhibitor of the protein kinase, mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) [1]. It is orally bioavailable and was tested in preclinical studies.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 1
Topological polar surface area 95.15
Molecular weight 374.12
XLogP 3.07
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1CNc2c(C(=O)N1)sc1c2c2ccc(nc2cc1)c1ccc(nc1)C
Isomeric SMILES C[C@@H]1CNc2c(C(=O)N1)sc1c2c2ccc(nc2cc1)c1ccc(nc1)C
InChI InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1
InChI Key CMWRPDHVGMHLSZ-GFCCVEGCSA-N
Bioactivity Comments
In vivo, PF-3644022 inhibits TNFα production in models of acute and chronic inflammation [1]. Off-targets include the related kinases MAPKAPK3 and MAPKAPK5.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
MAPK activated protein kinase 2 Primary target of this compound Hs Inhibitor Inhibition 8.5 pKi - 1
pKi 8.5 (Ki 3x10-9 M) [1]
MAPK activated protein kinase 2 Primary target of this compound Hs Inhibitor Inhibition 8.3 pIC50 - 1
pIC50 8.3 (IC50 5.2x10-9 M) [1]